about
Interleukin 5, IL6, IL12, IFN-gamma, RANTES and Fractalkine in human nasal polyps, turbinate mucosa and serumInfluenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza VaccinesThe humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice.Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination.Persistence and avidity maturation of antibodies to A(H1N1)pdm09 in healthcare workers following repeated annual vaccinations.A pilot study of the immune response to whole inactivated avian influenza H7N1 virus vaccine in mice.A cell-based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models.Pulmonary changes in Norwegian fatal cases of pandemic influenza H1N1 (2009) infection: a morphologic and molecular genetic study.The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants.The human immunodeficiency virus type 1 Rev protein shuttles between the cytoplasm and nuclear compartments.Mitochondrial protein p32 can accumulate in the nucleus.Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren's syndrome.Chemokines are secreted by monocytes following OK-432 (lyophilized Streptococcus pyogenes) stimulation.Allergic sensitisation in tuberculosis patients at the time of diagnosis and following chemotherapy.Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination.Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients.Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors.Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndromeLongevity of B-cell and T-cell responses after live attenuated influenza vaccination in children.Multiplex Analysis of Pro- or Anti-Inflammatory Serum Cytokines and Chemokines in relation to Gender and Age among Tanzanian Tuberculous Lymphadenitis Patients.Salivary glands of primary Sjögren's syndrome patients express factors vital for plasma cell survival.Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines.Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.Engraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression.Cytokine Concentrations in Plasma from Children with Severe and Non-Severe Community Acquired Pneumonia.Nuclear export of the human immunodeficiency virus type 1 nucleocytoplasmic shuttle protein Rev is mediated by its activation domain and is blocked by transdominant negative mutantsThe expression of B & T cell activation markers in children's tonsils following live attenuated influenza vaccineLocal and systemic cytokine and chemokine responses after parenteral influenza vaccination.Serum Markers in Rheumatoid Arthritis: A Longitudinal Study of Patients Undergoing Infliximab TreatmentRole of B cells in Sjögren's syndrome--from benign lymphoproliferation to overt malignancy.Sjögren's syndrome--a plethora of clinical and immunological phenotypes with a complex genetic background.Live Attenuated Influenza Vaccine in Children Induces B-Cell Responses in Tonsils.Axitinib blocks Wnt/β-catenin signaling and directs asymmetric cell division in cancerCalprotectin (S100A8/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis.25-Hydroxy-Vitamin D Concentration Is Not Affected by Severe or Non-Severe Pneumonia, or Inflammation, in Young Children.Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis.Atherosclerosis in Sjögren's syndrome: evidence, possible mechanisms and knowledge gaps.Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sjögren's syndrome.Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome.Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination.
P50
Q24303583-CAD9A125-94C7-42D4-B89C-90A2B42539D4Q26783844-EA6AAA61-C05D-4AE4-A8D0-B986518404C4Q30355478-88810DA0-9F3A-4B93-997D-8EA045E1697DQ30363826-629698A7-9E2F-4B86-A0A1-362E6C1A78D0Q30375477-86B2B6A7-A322-4A53-826A-4E960D88B117Q30377228-557D5628-859E-4804-8407-C423794E3C68Q30377246-8D3B6A8F-3113-4ED5-8F38-AFDA80C4E411Q30390515-E8A4A938-DD88-4B0E-8087-FB9B28181817Q30417273-2090277A-C7D3-48F3-8EB7-156E9371986BQ30450201-4C792055-F392-4013-B7C6-49ECF876DAF4Q32182067-8F98B6DF-BBE7-4A9C-BA3C-82053C84DB7BQ33185050-0C2604F1-FE36-4D65-8B04-D5681128EEAFQ33403628-17DEE458-176D-46B4-AF60-40D1454CDB05Q33475134-948FA023-C47B-48D9-BB52-D9C474F9F80CQ33770702-06622090-7BA9-4011-BE14-B650E4C2A6A8Q34543991-5ACEC1E3-616D-4306-BF1A-BF7DADA02A0CQ34556406-19F9703B-468A-464F-8C1A-4A81827BA9E8Q35082778-71D7C9EF-D746-4B8E-AF3C-5230E1EAAF66Q35531941-574BC5C9-292D-41CC-9634-F6BE80D48AC8Q35594683-EA97DDEC-32D7-4F11-A8D6-FBBF8847A2BBQ35620266-530CCF6B-4B82-42CE-A830-B2C8E17B4E86Q35629114-10425FF2-4738-46AB-8955-E64DAFD28FEDQ35677624-051BC2DA-AC30-403C-B730-74599F032E64Q35751304-2946E684-C9EE-4A23-A12E-26AAAC8B5024Q35788577-C259AC51-065A-444E-B8B6-0F3512A38750Q35839437-DAE4E542-F1B4-49E5-BABE-F8F57DAA2D4AQ35886894-1054FB83-EA7E-45DB-BA27-09469E2EF465Q36252434-2326CA3F-602A-4E7F-B46F-346C15D76441Q36415868-6CBB3BA5-D12C-4500-B9A3-45E9EFD2A580Q36664773-AC798D38-B346-4CB8-98D2-952E3CB7B493Q36951063-EF772A1F-E06D-462E-85E9-9439FD973C4DQ37161924-8D7DA3FA-E09D-404D-ABD3-45D01E4CC8DFQ37200030-249EFD62-1722-495C-871F-FC101ACCCB15Q37584844-AEFBE3F6-053E-4A71-878B-7DC8CD326297Q37628421-1521E7AD-CA7E-4A79-8E8C-A7AFBBDB7E94Q38621541-B122CAB3-012C-49F9-8203-12AA22D4C4B7Q38712129-EE34201F-22C1-4E60-B6AA-450146143A2AQ38956613-22AF749F-4616-46EE-B635-AFA60C42939CQ39166000-408B1AEB-8CFA-416F-A950-42C6E4E2429EQ39242282-F26FB624-991A-4FD4-8C0E-C68FD1B4E05F
P50
description
Noors onderzoeker
@nl
hulumtues
@sq
norsk forsker
@nb
researcher
@en
taighdeoir
@ga
հետազոտող
@hy
name
Karl A Brokstad
@ast
Karl A Brokstad
@es
Karl A Brokstad
@nl
Karl A Brokstad
@sl
Karl Albert Brokstad
@da
Karl Albert Brokstad
@de
Karl Albert Brokstad
@en
Karl Albert Brokstad
@fr
Karl Albert Brokstad
@ga
Karl Albert Brokstad
@nb
type
label
Karl A Brokstad
@ast
Karl A Brokstad
@es
Karl A Brokstad
@nl
Karl A Brokstad
@sl
Karl Albert Brokstad
@da
Karl Albert Brokstad
@de
Karl Albert Brokstad
@en
Karl Albert Brokstad
@fr
Karl Albert Brokstad
@ga
Karl Albert Brokstad
@nb
altLabel
Karl A Brokstad
@en
Karl A. Brokstad
@nb
Karl Brokstad
@nb
prefLabel
Karl A Brokstad
@ast
Karl A Brokstad
@es
Karl A Brokstad
@nl
Karl A Brokstad
@sl
Karl Albert Brokstad
@da
Karl Albert Brokstad
@de
Karl Albert Brokstad
@en
Karl Albert Brokstad
@fr
Karl Albert Brokstad
@ga
Karl Albert Brokstad
@nb
P106
P21
P27
P31
P496
0000-0003-0593-2731
P569
1961-01-01T00:00:00Z